Theravance Biopharma Ireland Limited – Trademark Portfolio
Entity Type: 99
Theravance Biopharma Ireland Limited holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 7 trademarks are registered and 1 is pending. Notable registered marks include BEVKI, HEVDUA, OMGEVI, UPBALA, and UPIQLA.
10 Earlsfort Terrace,
Dublin 2 D02 T380
Showing of trademarks Trademarks
Trademark Classifications
Theravance Biopharma Ireland Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Theravance Biopharma Ireland Limited have?
Theravance Biopharma Ireland Limited has 8 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 pending.
What trademark classes does Theravance Biopharma Ireland Limited file in?
Theravance Biopharma Ireland Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Theravance Biopharma Ireland Limited's most well-known trademarks?
Theravance Biopharma Ireland Limited's registered trademark portfolio includes well-known marks such as BEVKI, HEVDUA, OMGEVI, UPBALA, and UPIQLA. These are among 7 currently registered trademarks in the portfolio.
What is Theravance Biopharma Ireland Limited's trademark registration success rate?
Theravance Biopharma Ireland Limited has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 1 application is pending review.